Guggenheim Issues Positive Forecast for ADC Therapeutics (NYSE:ADCT) Stock Price
ADC Therapeutics (NYSE:ADCT – Free Report) had its target price upped by Guggenheim from $7.00 to $10.00 in a research report sent to investors on Friday,Benzinga reports. They currently have a buy rating on the stock. Several other brokerages have also recently commented on ADCT. Stephens boosted their price target on shares of ADC Therapeutics […]
ADC Therapeutics (NYSE:ADCT – Free Report) had its target price upped by Guggenheim from $7.00 to $10.00 in a research report sent to investors on Friday,Benzinga reports. They currently have a buy rating on the stock. Several other brokerages have also recently commented on ADCT. Stephens boosted their price target on shares of ADC Therapeutics […]
